Stay updated on Omalizumab in CRSwNP: Extension Study Clinical Trial
Sign up to get notified when there's something new on the Omalizumab in CRSwNP: Extension Study Clinical Trial page.

Latest updates to the Omalizumab in CRSwNP: Extension Study Clinical Trial page
- Check2 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study page is currently presenting a 403 Forbidden error page instead of the study details, with a simple Home link displayed on the error screen.SummaryDifference19%

- Check24 days agoChange DetectedThe page now displays a new revision tag, v3.7.0, indicating an update to the page's versioning metadata. The previous revision, v3.6.6, has been removed.SummaryDifference0.0%

- Check38 days agoChange DetectedUpdated the page revision label from v3.6.5 to v3.6.6, indicating a new revision of the document. This change does not modify the study content or user-facing information.SummaryDifference0.0%

- Check45 days agoChange DetectedAdds the NIH grant/contract annotation to the study's identifiers, placed with the EudraCT number. This reflects NIH funding associated with the trial.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor version update to the page documentation.SummaryDifference0.0%

Stay in the know with updates to Omalizumab in CRSwNP: Extension Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Omalizumab in CRSwNP: Extension Study Clinical Trial page.